Haemovigilance: are there significant differences among plasma products?

Area of Science:

• Transfusion Medicine
• Hematology
• Immunology

Background:

• Fresh frozen plasma (FFP) is a common blood product used for transfusion.
• Adverse reactions can occur following FFP administration.
• Solvent/detergent (S/D)-treated plasma is an alternative plasma product.

Purpose of the Study:

• To compare the adverse reaction profiles of single-donor FFP and pooled S/D-treated plasma.
• To identify specific transfusion reactions associated with each plasma product.

Main Methods:

• Analysis of reported adverse reactions.
• Comparison of incidence rates for specific transfusion reactions between FFP and S/D-treated plasma.

Main Results:

• Pooled S/D-treated plasma is significantly different from single-donor FFP regarding adverse reactions.
• Transfusion-associated acute lung injury and post-transfusion-thrombocytopenia are associated with FFP, not pooled S/D-treated plasma.
• Common acute reactions like fever, chills, and allergies occur less frequently with pooled S/D-treated plasma.

Conclusions:

• Pooled S/D-treated plasma offers a potentially safer alternative to FFP due to a lower incidence of severe and common adverse reactions.
• The distinct safety profiles warrant consideration in clinical transfusion decisions.